Author:
Ho Yuan-Soon,Lai Guan-Yi,Chan Hardy,Chen Tzu-Chi,Lee Wen-Jui
Reference37 articles.
1. Primary and secondary prevention of breast cancer;Kolak;Ann Agric Environ Med,2017
2. The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells;Cretella;J Exp Clin Cancer Res,2018
3. Clinical diagnosis and management of breast cancer;McDonald;J Nucl Med,2016
4. Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells;Cretella;Sci Rep,2019
5. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases;Aggarwal;Int J Biochem Cell Biol,2009